tickrz reports
Illumina Inc (ILMN)
Healthcare | Drugs
241.42  -1.35%
ILMN vs DRUGS SECTOR & S&P 500
VALUATION
ILMNSECTORS&P 500
P/E RATIO46.3440.521.12
EV/EBITDA RATIO30.69133.412.66
P/S RATIO13.976.52.25
P/B RATIO12.697.73.45
QUALITY
RETURN ON EQUITY27.27%15.79%13.64%
RETURN ON CAPITAL19.9%19.38%10.09%
NET MARGIN18.93%14.46%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATIO0.44%
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
5 OUT OF 9
DEBT-TO-EQUITY40%
INTEREST COVERAGE15.8x
CURRENT RATIO4.22
GROWTH
5 YR EPS GROWTH37.7%
5 YR SPS GROWTH17.84%
5 YR BPS GROWTH11.27%
Illumina Inc Filings

Annual & Quarterly Reports

Events or Changes Between Quarters (8-K)


Changes in Ownership